Tenaya Therapeutics, Inc. · NASDAQ:TNYA
Ali Faraz sold 3,499 Tenaya Therapeutics, Inc. shares (Form 4)
Traded Nov 17, 2026 · Filed Nov 18, 2026
On Nov 17, 2026, Ali Faraz (Director, Chief Executive Officer) sold 3,499 Tenaya Therapeutics, Inc. shares at US$0.32 for US$1,122, leaving 536,283 shares. Filed Nov 18, 2026 (Form 4).
- Sold
- 3,499 shares
- Price
- US$0.32
- Value
- US$1,122
- Holding after
- 536,283 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Stock | Sale | 3,499 | US$0.32 | 536,283 | Direct |
Source
Download original · View original at SEC
Related
- Tenaya Therapeutics, Inc.
- Ali Faraz
- Tenaya Therapeutics, Inc. shareholders
- Form 4 · Ali Faraz · Sep 11, 2026
- Form 4 · Ali Faraz · Aug 17, 2026
- Form 4 · Ali Faraz · May 19, 2026
- Form 4 · Tingley Whittemore · Nov 18, 2026
- Schedule 13D/A · The Column Group Opportunity III, LP · Nov 16, 2026
- Form 4 · Tingley Whittemore · Sep 11, 2026
- Schedule 13G · Millennium Management LLC · Aug 24, 2026
- Form 4 · Tingley Whittemore · Aug 17, 2026